ZA962177B - Once-a-month injectable composition as a depot contraceptive and for hormone replacement therapy for peri- and pre-menopausal women - Google Patents
Once-a-month injectable composition as a depot contraceptive and for hormone replacement therapy for peri- and pre-menopausal womenInfo
- Publication number
- ZA962177B ZA962177B ZA962177A ZA962177A ZA962177B ZA 962177 B ZA962177 B ZA 962177B ZA 962177 A ZA962177 A ZA 962177A ZA 962177 A ZA962177 A ZA 962177A ZA 962177 B ZA962177 B ZA 962177B
- Authority
- ZA
- South Africa
- Prior art keywords
- peri
- once
- replacement therapy
- injectable composition
- hormone replacement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19510861A DE19510861A1 (de) | 1995-03-16 | 1995-03-16 | Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA962177B true ZA962177B (en) | 1996-07-29 |
Family
ID=7757668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA962177A ZA962177B (en) | 1995-03-16 | 1996-03-18 | Once-a-month injectable composition as a depot contraceptive and for hormone replacement therapy for peri- and pre-menopausal women |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0814811A1 (es) |
| JP (1) | JPH11501649A (es) |
| KR (1) | KR19980703058A (es) |
| AR (1) | AR002283A1 (es) |
| AU (1) | AU713258B2 (es) |
| CA (1) | CA2215382A1 (es) |
| CZ (1) | CZ289697A3 (es) |
| DE (1) | DE19510861A1 (es) |
| HU (1) | HUP9801691A3 (es) |
| IL (1) | IL117516A (es) |
| MX (1) | MX9707009A (es) |
| NO (1) | NO974255L (es) |
| NZ (1) | NZ304027A (es) |
| PL (1) | PL322202A1 (es) |
| SK (1) | SK123997A3 (es) |
| WO (1) | WO1996028165A1 (es) |
| ZA (1) | ZA962177B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/de not_active Withdrawn
-
1996
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/cs unknown
- 1996-03-15 PL PL96322202A patent/PL322202A1/xx unknown
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/hu unknown
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/ko not_active Application Discontinuation
- 1996-03-15 EP EP96907506A patent/EP0814811A1/de not_active Withdrawn
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/de not_active Application Discontinuation
- 1996-03-15 AR ARP960101766A patent/AR002283A1/es unknown
- 1996-03-15 SK SK1239-97A patent/SK123997A3/sk unknown
- 1996-03-15 CA CA002215382A patent/CA2215382A1/en not_active Abandoned
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-15 MX MX9707009A patent/MX9707009A/es not_active IP Right Cessation
- 1996-03-15 JP JP8527295A patent/JPH11501649A/ja not_active Ceased
- 1996-03-15 NZ NZ304027A patent/NZ304027A/xx not_active IP Right Cessation
- 1996-03-17 IL IL11751696A patent/IL117516A/xx not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/xx unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL117516A0 (en) | 1996-07-23 |
| HUP9801691A2 (hu) | 1998-11-30 |
| AU5110896A (en) | 1996-10-02 |
| EP0814811A1 (de) | 1998-01-07 |
| NZ304027A (en) | 2000-05-26 |
| NO974255D0 (no) | 1997-09-15 |
| MX9707009A (es) | 1997-11-29 |
| CA2215382A1 (en) | 1996-09-19 |
| CZ289697A3 (en) | 1997-12-17 |
| HUP9801691A3 (en) | 1999-03-01 |
| SK123997A3 (en) | 1998-02-04 |
| PL322202A1 (en) | 1998-01-19 |
| AU713258B2 (en) | 1999-11-25 |
| JPH11501649A (ja) | 1999-02-09 |
| NO974255L (no) | 1997-11-14 |
| IL117516A (en) | 2000-07-26 |
| KR19980703058A (ko) | 1998-09-05 |
| DE19510861A1 (de) | 1996-09-19 |
| WO1996028165A1 (de) | 1996-09-19 |
| AR002283A1 (es) | 1998-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2320190B (en) | Total hormone replacement therapy | |
| IL116743A0 (en) | Pharmaceutical composition comprising a growth hormone | |
| HUP9602982A3 (en) | Multiplase composition for contraception based on natural eostrogene | |
| EP0741578A4 (en) | HUMAN GROWTH HORMONE | |
| HUP9900301A3 (en) | Hormone patch | |
| HUP9900870A3 (en) | Composition for sustained release of human growth hormone | |
| HU9700777D0 (en) | Estrogenic agents, process for producing them and pharmaceutical compositions containing them | |
| HU9700779D0 (en) | Estrogenic agents, process for producing them and pharmaceutical compositions containing them | |
| GB2276053B (en) | Direct digital synthesizer | |
| HUP9802608A3 (en) | Hormone replacement therapy method and hormone dispenser | |
| ZA966891B (en) | 2-acylaminopropanamines as growth hormone secretagogues. | |
| GB9607964D0 (en) | Soft lining material composition for dentures | |
| GB9216775D0 (en) | Orthopaedic splinting/casting material | |
| HUP9900612A3 (en) | Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies | |
| GB9518611D0 (en) | Anti-apoptotic factors | |
| ZA962177B (en) | Once-a-month injectable composition as a depot contraceptive and for hormone replacement therapy for peri- and pre-menopausal women | |
| IL116742A0 (en) | Pharmaceutical composition comprising a growth hormone | |
| IL116741A0 (en) | Pharmaceutical composition comprising a growth hormone | |
| NZ268125A (en) | Growth hormone pharmaceutical composition | |
| GB9615350D0 (en) | Hormone replacement therapy | |
| GB9407654D0 (en) | Liner | |
| HU9603110D0 (en) | Synthesis of 17beta-cyano-3-ethoxy-17alfa-hydroxy-6-methylandrosta-3,5,9(11)-triene | |
| ZA924419B (en) | Discharge liner | |
| GB9414001D0 (en) | Orthopaedic splinting material | |
| CA75791S (en) | Tie down strap |